Global X HealthTech ETF HEAL
30.45 USD -0.54 (-1.76%)
Nov 12, 2026, 2:31 PM EST
30.17 Day range 30.69
23.00 52-week range 32.15
- YTD
- +4.19%
- 1 year
- -1.25%
News
newsfilecorp.com Restart Life Advances Youth+love Collagen Toward Planned 2027 Launch Vancouver, British Columbia--(Newsfile Corp. - November 12, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that…
benzinga.com What's Going On With Tempus AI Stock Monday? Ambry Genetics, a subsidiary of Tempus AI, announced completion of 1 million DNA/RNA tests for hereditary cancer and rare disease.
benzinga.com Trump's Weight-Loss Drug Push May Put These ETFs On A Diet Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
benzinga.com Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom.
benzinga.com Samsung's Xealth Acquisition Connects Patient Data To Clinical Care Samsung to acquire Xealth, a digital health platform that integrates patient data from devices to improve personalized healthcare.